Australia Stock Exchange release from PHARMAUST : Appendix 4C and Quarterly Update
30/01/2022 23:00
Australia Stock Exchange release from PHARMAUST PAA.AX : Appendix 4C and Quarterly Update
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility